Last week, the Center for Research in Biological Chemistry and Molecular Materials (CiQUS) welcomed its Industrial Advisory Board (IAB). During the visit, members of the IAB engaged in various meetings with CiQUS management and its transfer team, toured the facilities, and met with the center's research and technical staff. The gathering served as an introductory session, allowing the panel of experts to familiarize themselves with the technological developments at CiQUS and exchange insights on best practices in public-private collaboration.
CiQUS Industrial Advisory Board comprises seven distinguished professionals in innovation and transfer: Paul Burke (Burke Bioventures LLC), Santiago Domínguez (Bruker & Mestrelab Research), Jesús Castañon (Eli Lilly & Co.), Carme Pampín (GalChimia), Ben Janeiro (ABCR Labs), Manuel Lolo (AMSlab), and Susana Torrente (AVTE USC). Their extensive experience and broad vision within sectors relevant to CiQUS will now play a pivotal role in shaping the center's transfer strategy and fostering cooperation with industry.
In recent years, CiQUS has intensified its efforts to transfer knowledge generated at the center to the industry and society at large, by implementing a valorization model that has strengthened entrepreneurship and relationships with companies and research centers. Consequently, various technologies developed at CiQUS have received support from leading European, national, and regional programs aimed at financing their maturation and advancing their market development. Just a year ago, the TraffikGene project secured EIC-Transition funding to mature its technology, the only one of its kind granted in Galicia. But there's more: 4 ERC Proof of Concept projects, 2 CaixaResearch projects, success in projects focused on ecological transition, and 3 IGNICIA projects from the Xunta de Galicia, one of which has already led to the creation of Celtarys. These are just a few examples of the growing interest in the innovative technologies emerging from CiQUS.
From left to right: Dolores Pérez (CiQUS), Fernando Casal (CiQUS), Jesús Castañon (Eli Lilly & co.), Carme Pampín (GalChimia), Susana Torrente (AVTE USC), Paul Burke (Burke Bioventures LLC), Ben Janeiro (ABCR Labs), José Luis Mascareñas (CiQUS) & Almudena García (CiQUS).